Val66Met polymorphism and BDNF levels in Alzheimer's disease patients in North Indian population

References

• McKhann G, Drachman D, Folstein M, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34(7):939–44.
   PubMed Web of Science ®Google Scholar
• Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82(4):239–59.
   PubMed Web of Science ®Google Scholar
• Combarros O, Infante J, Llorca J, Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 2004;18(1):55–8.
   Google Scholar
• Winblad B, Palmer K, Kivipelto M, Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256(3):240–6.
   PubMed Web of Science ®Google Scholar
• Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256(3):183–94.
   PubMed Web of Science ®Google Scholar
• Tapia-Arancibia L, Aliaga E, Silhol M, New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev 2008;59(1):201–20.
   PubMed Web of Science ®Google Scholar
• Schindowski K, Belarbi K, Buee L. Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav 2008;7(Suppl 1):43–56.
   Google Scholar
• Kukull WA, Higdon R, Bowen JD, Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol 2002;59(11):1737–46.
   PubMedGoogle Scholar
• Murer MG, Boissiere F, Yan Q, An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience 1999;88(4):1015–32.
   Google Scholar
• Murer MG, Yan Q, Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 2001;63(1):71–124.
   PubMed Web of Science ®Google Scholar
• Nagahara AH, Merrill DA, Coppola G, Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 2009;15(3):331–7.
   PubMed Web of Science ®Google Scholar
• Peng S, Wuu J, Mufson EJ, Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem 2005;93(6):1412–21.
   PubMed Web of Science ®Google Scholar
• Holsinger RM, Schnarr J, Henry P, Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. Brain Res Mol Brain Res 2000;76(2):347–54.
   PubMedGoogle Scholar
• Connor B, Young D, Yan Q, Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain research. Mol Brain Res 1997;49(1–2):71–81.
   PubMedGoogle Scholar
• Laske C, Stellos K, Hoffmann N, Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients. Int J Neuropsychopharmacol 2011;14(3):399–404.
   Google Scholar
• Laske C, Stransky E, Leyhe T, Stage-dependent BDNF serum concentrations in Alzheimer's disease. J Neural Transm 2006;113(9):1217–24.
   PubMed Web of Science ®Google Scholar
• Yu H, Zhang Z, Shi Y, Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. J Clin Psychiatry 2008;69(7):1104–11.
   PubMed Web of Science ®Google Scholar
• O'Bryant SE, Hobson V, Hall JR, Brain-derived neurotrophic factor levels in Alzheimer's disease. J Alzheimers Dis 2009;17(2):337–41.
   PubMed Web of Science ®Google Scholar
• Maisonpierre PC, Le Beau MM, Espinosa R III, Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 1991;10(3):558–68.
   PubMed Web of Science ®Google Scholar
• Ventriglia M, Bocchio Chiavetto L, Benussi L, Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol Psychiatry 2002;7(2):136–7.
   PubMed Web of Science ®Google Scholar
• Leyhe T, Stransky E, Eschweiler GW, Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 2008;258(2):124–8.
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3):189–98.
   PubMed Web of Science ®Google Scholar
• Hughes CP, Berg L, Danziger WL, A new clinical scale for the staging of dementia. Br J Psychiatry (the journal of mental science). 1982;140:566–72.
   Google Scholar
• Petersen RC, Smith GE, Waring SC, Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56(3):303–8.
   PubMed Web of Science ®Google Scholar
• Carlesimo GA, Caltagirone C, Gainotti G. The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 1996;36(6):378–84.
   PubMed Web of Science ®Google Scholar
• Shimizu E, Hashimoto K, Iyo M. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet (the official publication of the International Society of Psychiatric Genetics) 2004;126B(1):122–3.
   Google Scholar
• Pivac N, Nikolac M, Nedic G, Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2011;35(2):356–62.
   Google Scholar
• Angelucci F, Spalletta G, di Iulio F, Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients are characterized by increased BDNF serum levels. Curr Alzheimer Res 2010;7(1):15–20.
   PubMed Web of Science ®Google Scholar
• Durany N, Michel T, Kurt J, Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains. Int J Dev Neurosci 2000;18(8):807–13.
   Google Scholar
• Marmigere F, Choby C, Rage F, Rapid stimulatory effects of brain-derived neurotrophic factor and neurotrophin-3 on somatostatin release and intracellular calcium rise in primary hypothalamic cell cultures. Neuroendocrinology 2001;74(1):43–54.
   Google Scholar
• Villuendas G, Sanchez-Franco F, Palacios N, Involvement of VIP on BDNF-induced somatostatin gene expression in cultured fetal rat cerebral cortical cells. Brain research. Mol Brain Res 2001;94(1–2):59–66.
   Google Scholar
• Foulstone EJ, Tavare JM, Gunn-Moore FJ. Sustained phosphorylation and activation of protein kinase B correlates with brain-derived neurotrophic factor and insulin stimulated survival of cerebellar granule cells. Neurosci Lett 1999;264(1–3):125–8.
   Google Scholar
• Leroy K, Boutajangout A, Authelet M, The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Acta Neuropathol 2002;103(2):91–9.
   Google Scholar
• Schmidt HD, Duman RS. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 2007;18(5–6):391–418.
   Web of Science ®Google Scholar
• Kozisek ME, Middlemas D, Bylund DB. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Ther 2008;117(1):30–51.
   PubMed Web of Science ®Google Scholar
• Ferrer I, Marin C, Rey MJ, BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol 1999;58(7):729–39.
   PubMed Web of Science ®Google Scholar
• Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008;64(6):527–32.
   PubMed Web of Science ®Google Scholar
• Nagata T, Shinagawa S, Nukariya K, Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease. Psychogeriatrics 2011;11(3):141–9.
   PubMed Web of Science ®Google Scholar
• Zhang L, Fang Y, Zeng Z, BDNF gene polymorphisms are associated with Alzheimer's disease-related depression and antidepressant response. J Alzheimers Dis 2011;26(3):523–30.
   Google Scholar
• Diniz BS, Teixeira AL. Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond. Neuromolecular Med 2011;13(4):217–22.
   PubMed Web of Science ®Google Scholar
• O'Bryant SE, Hobson VL, Hall JR, Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases. Dement Geriatr Cogn Disord 2011;31(1):31–6.
   Google Scholar
• Ziegenhorn AA, Schulte-Herbruggen O, Danker-Hopfe H, Serum neurotrophins – a study on the time course and influencing factors in a large old age sample. Neurobiol Aging 2007;28(9):1436–45.
   PubMed Web of Science ®Google Scholar